nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0975	0.16	CbGbCtD
Iloperidone—CYP3A7—Irinotecan—colon cancer	0.0975	0.16	CbGbCtD
Iloperidone—CYP3A7—Vincristine—colon cancer	0.0852	0.14	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0852	0.14	CbGbCtD
Iloperidone—CYP3A5—Irinotecan—colon cancer	0.0731	0.12	CbGbCtD
Iloperidone—CYP3A5—Vincristine—colon cancer	0.0639	0.105	CbGbCtD
Iloperidone—CYP1A2—Fluorouracil—colon cancer	0.0522	0.0859	CbGbCtD
Iloperidone—CYP3A4—Irinotecan—colon cancer	0.0285	0.0469	CbGbCtD
Iloperidone—CYP3A4—Vincristine—colon cancer	0.0249	0.041	CbGbCtD
Iloperidone—Walking disability—Vincristine—colon cancer	0.0201	0.0776	CcSEcCtD
Iloperidone—HTR7—myenteric nerve plexus—colon cancer	0.0182	0.144	CbGeAlD
Iloperidone—Walking disability—Capecitabine—colon cancer	0.0131	0.0506	CcSEcCtD
Iloperidone—HTR7—vein—colon cancer	0.0117	0.0931	CbGeAlD
Iloperidone—HTR2A—myenteric nerve plexus—colon cancer	0.0114	0.0901	CbGeAlD
Iloperidone—HTR2A—vein—colon cancer	0.00732	0.058	CbGeAlD
Iloperidone—Dyspnoea exertional—Capecitabine—colon cancer	0.005	0.0193	CcSEcCtD
Iloperidone—Parkinsonism—Fluorouracil—colon cancer	0.00476	0.0184	CcSEcCtD
Iloperidone—HTR1D—blood vessel—colon cancer	0.00467	0.0371	CbGeAlD
Iloperidone—Akathisia—Irinotecan—colon cancer	0.00408	0.0157	CcSEcCtD
Iloperidone—Panic attack—Capecitabine—colon cancer	0.00405	0.0157	CcSEcCtD
Iloperidone—HTR7—endothelium—colon cancer	0.00404	0.032	CbGeAlD
Iloperidone—Gefitinib—EGFR—colon cancer	0.00399	0.57	CrCbGaD
Iloperidone—HTR7—blood vessel—colon cancer	0.00372	0.0295	CbGeAlD
Iloperidone—Blepharitis—Fluorouracil—colon cancer	0.00351	0.0136	CcSEcCtD
Iloperidone—Nystagmus—Vincristine—colon cancer	0.00324	0.0125	CcSEcCtD
Iloperidone—Menorrhagia—Vincristine—colon cancer	0.00313	0.0121	CcSEcCtD
Iloperidone—Nystagmus—Fluorouracil—colon cancer	0.00303	0.0117	CcSEcCtD
Iloperidone—Haematocrit decreased—Methotrexate—colon cancer	0.00302	0.0117	CcSEcCtD
Iloperidone—HTR2A—endothelium—colon cancer	0.00252	0.02	CbGeAlD
Iloperidone—Gait disturbance—Vincristine—colon cancer	0.00237	0.00917	CcSEcCtD
Iloperidone—Hypothyroidism—Capecitabine—colon cancer	0.00235	0.00909	CcSEcCtD
Iloperidone—HTR2A—blood vessel—colon cancer	0.00232	0.0184	CbGeAlD
Iloperidone—Gait disturbance—Irinotecan—colon cancer	0.00231	0.00893	CcSEcCtD
Iloperidone—CYP3A7—liver—colon cancer	0.00225	0.0178	CbGeAlD
Iloperidone—Haemoglobin decreased—Capecitabine—colon cancer	0.00219	0.00848	CcSEcCtD
Iloperidone—Salivary hypersecretion—Irinotecan—colon cancer	0.00219	0.00846	CcSEcCtD
Iloperidone—Metrorrhagia—Capecitabine—colon cancer	0.00211	0.00817	CcSEcCtD
Iloperidone—Mouth ulceration—Vincristine—colon cancer	0.0021	0.00809	CcSEcCtD
Iloperidone—SIGMAR1—smooth muscle tissue—colon cancer	0.00204	0.0162	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—liver—colon cancer	0.00191	0.0151	CbGeAlD
Iloperidone—Rhinorrhoea—Capecitabine—colon cancer	0.00186	0.0072	CcSEcCtD
Iloperidone—HTR7—epithelium—colon cancer	0.00181	0.0144	CbGeAlD
Iloperidone—Risperidone—ABCB1—colon cancer	0.0018	0.257	CrCbGaD
Iloperidone—Renal failure acute—Irinotecan—colon cancer	0.00177	0.00685	CcSEcCtD
Iloperidone—HTR1A—renal system—colon cancer	0.00176	0.014	CbGeAlD
Iloperidone—ADRA1A—epithelium—colon cancer	0.00175	0.0139	CbGeAlD
Iloperidone—HTR7—smooth muscle tissue—colon cancer	0.00175	0.0138	CbGeAlD
Iloperidone—Musculoskeletal stiffness—Capecitabine—colon cancer	0.00168	0.0065	CcSEcCtD
Iloperidone—HTR7—renal system—colon cancer	0.00168	0.0133	CbGeAlD
Iloperidone—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.00167	0.00646	CcSEcCtD
Iloperidone—Amnesia—Fluorouracil—colon cancer	0.00167	0.00645	CcSEcCtD
Iloperidone—ADRA1A—renal system—colon cancer	0.00162	0.0129	CbGeAlD
Iloperidone—Cardiac failure—Fluorouracil—colon cancer	0.00161	0.00621	CcSEcCtD
Iloperidone—Lethargy—Fluorouracil—colon cancer	0.0016	0.00618	CcSEcCtD
Iloperidone—Urinary retention—Vincristine—colon cancer	0.0016	0.00618	CcSEcCtD
Iloperidone—Cataract—Capecitabine—colon cancer	0.00159	0.00613	CcSEcCtD
Iloperidone—Dehydration—Vincristine—colon cancer	0.00156	0.00604	CcSEcCtD
Iloperidone—Gait disturbance—Capecitabine—colon cancer	0.00155	0.00598	CcSEcCtD
Iloperidone—ADRA2C—renal system—colon cancer	0.00155	0.0123	CbGeAlD
Iloperidone—Dehydration—Irinotecan—colon cancer	0.00152	0.00588	CcSEcCtD
Iloperidone—Orthostatic hypotension—Irinotecan—colon cancer	0.0015	0.00578	CcSEcCtD
Iloperidone—Hypokalaemia—Irinotecan—colon cancer	0.00149	0.00576	CcSEcCtD
Iloperidone—SIGMAR1—bone marrow—colon cancer	0.00149	0.0118	CbGeAlD
Iloperidone—Urinary incontinence—Capecitabine—colon cancer	0.00146	0.00563	CcSEcCtD
Iloperidone—Fluid retention—Capecitabine—colon cancer	0.00143	0.00554	CcSEcCtD
Iloperidone—SIGMAR1—vagina—colon cancer	0.00143	0.0113	CbGeAlD
Iloperidone—Nasopharyngitis—Fluorouracil—colon cancer	0.0014	0.00542	CcSEcCtD
Iloperidone—Dry eye—Capecitabine—colon cancer	0.0014	0.00539	CcSEcCtD
Iloperidone—HTR2A—embryo—colon cancer	0.00139	0.011	CbGeAlD
Iloperidone—HTR7—digestive system—colon cancer	0.00138	0.0109	CbGeAlD
Iloperidone—Mouth ulceration—Capecitabine—colon cancer	0.00137	0.00527	CcSEcCtD
Iloperidone—Dysuria—Vincristine—colon cancer	0.00136	0.00525	CcSEcCtD
Iloperidone—HRH1—epithelium—colon cancer	0.00135	0.0107	CbGeAlD
Iloperidone—ADRA1A—lymphoid tissue—colon cancer	0.00135	0.0107	CbGeAlD
Iloperidone—CYP1A2—renal system—colon cancer	0.00134	0.0106	CbGeAlD
Iloperidone—Erectile dysfunction—Vincristine—colon cancer	0.00134	0.00517	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Irinotecan—colon cancer	0.00132	0.00508	CcSEcCtD
Iloperidone—Weight decreased—Vincristine—colon cancer	0.00132	0.00508	CcSEcCtD
Iloperidone—HRH1—smooth muscle tissue—colon cancer	0.0013	0.0103	CbGeAlD
Iloperidone—CYP3A5—renal system—colon cancer	0.00129	0.0103	CbGeAlD
Iloperidone—Weight decreased—Irinotecan—colon cancer	0.00128	0.00495	CcSEcCtD
Iloperidone—Stomatitis—Vincristine—colon cancer	0.00126	0.00488	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00126	0.00487	CcSEcCtD
Iloperidone—Musculoskeletal stiffness—Methotrexate—colon cancer	0.00125	0.00484	CcSEcCtD
Iloperidone—Stomatitis—Irinotecan—colon cancer	0.00123	0.00475	CcSEcCtD
Iloperidone—Gefitinib—ABCB1—colon cancer	0.00121	0.173	CrCbGaD
Iloperidone—CYP2E1—renal system—colon cancer	0.00121	0.00957	CbGeAlD
Iloperidone—SIGMAR1—liver—colon cancer	0.0012	0.00954	CbGeAlD
Iloperidone—Renal failure acute—Capecitabine—colon cancer	0.00119	0.00459	CcSEcCtD
Iloperidone—Libido decreased—Capecitabine—colon cancer	0.00118	0.00457	CcSEcCtD
Iloperidone—Stomatitis—Fluorouracil—colon cancer	0.00118	0.00455	CcSEcCtD
Iloperidone—Conjunctivitis—Fluorouracil—colon cancer	0.00118	0.00454	CcSEcCtD
Iloperidone—Amnesia—Capecitabine—colon cancer	0.00117	0.00451	CcSEcCtD
Iloperidone—Increased appetite—Capecitabine—colon cancer	0.00117	0.00451	CcSEcCtD
Iloperidone—Thirst—Capecitabine—colon cancer	0.00115	0.00445	CcSEcCtD
Iloperidone—Urinary tract disorder—Vincristine—colon cancer	0.00115	0.00444	CcSEcCtD
Iloperidone—Connective tissue disorder—Vincristine—colon cancer	0.00114	0.00442	CcSEcCtD
Iloperidone—Urethral disorder—Vincristine—colon cancer	0.00114	0.00441	CcSEcCtD
Iloperidone—Epistaxis—Fluorouracil—colon cancer	0.00114	0.0044	CcSEcCtD
Iloperidone—HTR2A—epithelium—colon cancer	0.00113	0.00896	CbGeAlD
Iloperidone—Cardiac failure—Capecitabine—colon cancer	0.00112	0.00434	CcSEcCtD
Iloperidone—ADRA2C—vagina—colon cancer	0.00112	0.00888	CbGeAlD
Iloperidone—Lethargy—Capecitabine—colon cancer	0.00112	0.00432	CcSEcCtD
Iloperidone—Connective tissue disorder—Irinotecan—colon cancer	0.00111	0.0043	CcSEcCtD
Iloperidone—CYP1A2—digestive system—colon cancer	0.0011	0.00872	CbGeAlD
Iloperidone—HTR2A—smooth muscle tissue—colon cancer	0.00109	0.00864	CbGeAlD
Iloperidone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00109	0.0042	CcSEcCtD
Iloperidone—Cardiac disorder—Vincristine—colon cancer	0.00108	0.00417	CcSEcCtD
Iloperidone—CYP3A5—digestive system—colon cancer	0.00106	0.00841	CbGeAlD
Iloperidone—Angiopathy—Vincristine—colon cancer	0.00106	0.00408	CcSEcCtD
Iloperidone—Cardiac disorder—Irinotecan—colon cancer	0.00105	0.00406	CcSEcCtD
Iloperidone—Mediastinal disorder—Vincristine—colon cancer	0.00105	0.00405	CcSEcCtD
Iloperidone—HTR2A—renal system—colon cancer	0.00105	0.00831	CbGeAlD
Iloperidone—Urinary retention—Capecitabine—colon cancer	0.00104	0.00403	CcSEcCtD
Iloperidone—Mood swings—Capecitabine—colon cancer	0.00104	0.00401	CcSEcCtD
Iloperidone—HRH1—digestive system—colon cancer	0.00103	0.00816	CbGeAlD
Iloperidone—Angiopathy—Irinotecan—colon cancer	0.00103	0.00397	CcSEcCtD
Iloperidone—HTR7—liver—colon cancer	0.00103	0.00815	CbGeAlD
Iloperidone—Mediastinal disorder—Irinotecan—colon cancer	0.00102	0.00394	CcSEcCtD
Iloperidone—Dehydration—Capecitabine—colon cancer	0.00102	0.00394	CcSEcCtD
Iloperidone—Mental disorder—Vincristine—colon cancer	0.00102	0.00394	CcSEcCtD
Iloperidone—Mouth ulceration—Methotrexate—colon cancer	0.00102	0.00393	CcSEcCtD
Iloperidone—Arrhythmia—Irinotecan—colon cancer	0.00101	0.00391	CcSEcCtD
Iloperidone—Gynaecomastia—Methotrexate—colon cancer	0.00101	0.00389	CcSEcCtD
Iloperidone—CYP2E1—lymphoid tissue—colon cancer	0.001	0.00794	CbGeAlD
Iloperidone—Orthostatic hypotension—Capecitabine—colon cancer	0.001	0.00387	CcSEcCtD
Iloperidone—Hypokalaemia—Capecitabine—colon cancer	0.000998	0.00385	CcSEcCtD
Iloperidone—ADRA1A—liver—colon cancer	0.000991	0.00786	CbGeAlD
Iloperidone—Breast disorder—Capecitabine—colon cancer	0.000991	0.00383	CcSEcCtD
Iloperidone—CYP2E1—digestive system—colon cancer	0.000989	0.00785	CbGeAlD
Iloperidone—Nasopharyngitis—Capecitabine—colon cancer	0.00098	0.00379	CcSEcCtD
Iloperidone—CYP3A4—renal system—colon cancer	0.00097	0.0077	CbGeAlD
Iloperidone—Gastritis—Capecitabine—colon cancer	0.00097	0.00375	CcSEcCtD
Iloperidone—Arrhythmia—Fluorouracil—colon cancer	0.00097	0.00375	CcSEcCtD
Iloperidone—CYP2D6—renal system—colon cancer	0.000955	0.00757	CbGeAlD
Iloperidone—Muscle spasms—Irinotecan—colon cancer	0.000949	0.00366	CcSEcCtD
Iloperidone—Asthma—Capecitabine—colon cancer	0.000948	0.00366	CcSEcCtD
Iloperidone—ADRA2C—liver—colon cancer	0.000944	0.00749	CbGeAlD
Iloperidone—CYP3A5—vagina—colon cancer	0.000937	0.00743	CbGeAlD
Iloperidone—Anaemia—Vincristine—colon cancer	0.000936	0.00362	CcSEcCtD
Iloperidone—Agitation—Vincristine—colon cancer	0.000931	0.0036	CcSEcCtD
Iloperidone—SIGMAR1—lymph node—colon cancer	0.000922	0.00731	CbGeAlD
Iloperidone—Anaemia—Irinotecan—colon cancer	0.000912	0.00352	CcSEcCtD
Iloperidone—Vertigo—Vincristine—colon cancer	0.00091	0.00352	CcSEcCtD
Iloperidone—HRH1—vagina—colon cancer	0.000909	0.00721	CbGeAlD
Iloperidone—Abdominal discomfort—Capecitabine—colon cancer	0.000908	0.00351	CcSEcCtD
Iloperidone—Leukopenia—Vincristine—colon cancer	0.000907	0.0035	CcSEcCtD
Iloperidone—ADRA2A—vagina—colon cancer	0.000893	0.00708	CbGeAlD
Iloperidone—Vision blurred—Fluorouracil—colon cancer	0.00089	0.00344	CcSEcCtD
Iloperidone—Vertigo—Irinotecan—colon cancer	0.000886	0.00342	CcSEcCtD
Iloperidone—Dysuria—Capecitabine—colon cancer	0.000886	0.00342	CcSEcCtD
Iloperidone—Renal failure acute—Methotrexate—colon cancer	0.000884	0.00341	CcSEcCtD
Iloperidone—Leukopenia—Irinotecan—colon cancer	0.000883	0.00341	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Capecitabine—colon cancer	0.000881	0.0034	CcSEcCtD
Iloperidone—Anaemia—Fluorouracil—colon cancer	0.000873	0.00337	CcSEcCtD
Iloperidone—Myalgia—Vincristine—colon cancer	0.000862	0.00333	CcSEcCtD
Iloperidone—Weight increased—Capecitabine—colon cancer	0.000862	0.00333	CcSEcCtD
Iloperidone—HTR2A—digestive system—colon cancer	0.00086	0.00682	CbGeAlD
Iloperidone—Weight decreased—Capecitabine—colon cancer	0.000857	0.00331	CcSEcCtD
Iloperidone—Leukopenia—Fluorouracil—colon cancer	0.000846	0.00327	CcSEcCtD
Iloperidone—Lethargy—Methotrexate—colon cancer	0.000833	0.00322	CcSEcCtD
Iloperidone—Oedema—Vincristine—colon cancer	0.000827	0.00319	CcSEcCtD
Iloperidone—Stomatitis—Capecitabine—colon cancer	0.000824	0.00318	CcSEcCtD
Iloperidone—Infection—Vincristine—colon cancer	0.000821	0.00317	CcSEcCtD
Iloperidone—Conjunctivitis—Capecitabine—colon cancer	0.000821	0.00317	CcSEcCtD
Iloperidone—CYP1A2—liver—colon cancer	0.000819	0.0065	CbGeAlD
Iloperidone—Confusional state—Irinotecan—colon cancer	0.000812	0.00314	CcSEcCtD
Iloperidone—Nervous system disorder—Vincristine—colon cancer	0.000811	0.00313	CcSEcCtD
Iloperidone—Oedema—Irinotecan—colon cancer	0.000805	0.00311	CcSEcCtD
Iloperidone—Myalgia—Fluorouracil—colon cancer	0.000804	0.00311	CcSEcCtD
Iloperidone—Infection—Irinotecan—colon cancer	0.0008	0.00309	CcSEcCtD
Iloperidone—Hepatobiliary disease—Capecitabine—colon cancer	0.000799	0.00309	CcSEcCtD
Iloperidone—Epistaxis—Capecitabine—colon cancer	0.000797	0.00308	CcSEcCtD
Iloperidone—CYP3A4—digestive system—colon cancer	0.000796	0.00631	CbGeAlD
Iloperidone—CYP3A5—liver—colon cancer	0.00079	0.00627	CbGeAlD
Iloperidone—Nervous system disorder—Irinotecan—colon cancer	0.00079	0.00305	CcSEcCtD
Iloperidone—CYP2D6—digestive system—colon cancer	0.000783	0.00621	CbGeAlD
Iloperidone—Confusional state—Fluorouracil—colon cancer	0.000778	0.003	CcSEcCtD
Iloperidone—Mood swings—Methotrexate—colon cancer	0.000773	0.00299	CcSEcCtD
Iloperidone—Hypotension—Vincristine—colon cancer	0.000773	0.00298	CcSEcCtD
Iloperidone—Oedema—Fluorouracil—colon cancer	0.000771	0.00298	CcSEcCtD
Iloperidone—Infection—Fluorouracil—colon cancer	0.000766	0.00296	CcSEcCtD
Iloperidone—HTR2A—vagina—colon cancer	0.000759	0.00602	CbGeAlD
Iloperidone—Nervous system disorder—Fluorouracil—colon cancer	0.000756	0.00292	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000753	0.00291	CcSEcCtD
Iloperidone—Tachycardia—Fluorouracil—colon cancer	0.000753	0.00291	CcSEcCtD
Iloperidone—Hypotension—Irinotecan—colon cancer	0.000752	0.00291	CcSEcCtD
Iloperidone—Urinary tract disorder—Capecitabine—colon cancer	0.000749	0.00289	CcSEcCtD
Iloperidone—Connective tissue disorder—Capecitabine—colon cancer	0.000745	0.00288	CcSEcCtD
Iloperidone—Urethral disorder—Capecitabine—colon cancer	0.000744	0.00287	CcSEcCtD
Iloperidone—Paraesthesia—Vincristine—colon cancer	0.000742	0.00287	CcSEcCtD
Iloperidone—Breast disorder—Methotrexate—colon cancer	0.000738	0.00285	CcSEcCtD
Iloperidone—CYP2E1—liver—colon cancer	0.000737	0.00585	CbGeAlD
Iloperidone—ADRA2C—lymph node—colon cancer	0.000724	0.00574	CbGeAlD
Iloperidone—Paraesthesia—Irinotecan—colon cancer	0.000723	0.00279	CcSEcCtD
Iloperidone—Hypotension—Fluorouracil—colon cancer	0.000721	0.00278	CcSEcCtD
Iloperidone—Dyspnoea—Irinotecan—colon cancer	0.000718	0.00277	CcSEcCtD
Iloperidone—Somnolence—Irinotecan—colon cancer	0.000716	0.00276	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Vincristine—colon cancer	0.000714	0.00276	CcSEcCtD
Iloperidone—Fatigue—Vincristine—colon cancer	0.000713	0.00275	CcSEcCtD
Iloperidone—Eye disorder—Capecitabine—colon cancer	0.000709	0.00274	CcSEcCtD
Iloperidone—Tinnitus—Capecitabine—colon cancer	0.000707	0.00273	CcSEcCtD
Iloperidone—Asthma—Methotrexate—colon cancer	0.000705	0.00272	CcSEcCtD
Iloperidone—Cardiac disorder—Capecitabine—colon cancer	0.000704	0.00272	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000703	0.00271	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000695	0.00268	CcSEcCtD
Iloperidone—Fatigue—Irinotecan—colon cancer	0.000694	0.00268	CcSEcCtD
Iloperidone—Paraesthesia—Fluorouracil—colon cancer	0.000692	0.00267	CcSEcCtD
Iloperidone—Angiopathy—Capecitabine—colon cancer	0.000688	0.00266	CcSEcCtD
Iloperidone—Dyspnoea—Fluorouracil—colon cancer	0.000688	0.00266	CcSEcCtD
Iloperidone—Somnolence—Fluorouracil—colon cancer	0.000686	0.00265	CcSEcCtD
Iloperidone—Mediastinal disorder—Capecitabine—colon cancer	0.000684	0.00264	CcSEcCtD
Iloperidone—Arrhythmia—Capecitabine—colon cancer	0.000678	0.00262	CcSEcCtD
Iloperidone—Abdominal discomfort—Methotrexate—colon cancer	0.000676	0.00261	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000666	0.00257	CcSEcCtD
Iloperidone—Mental disorder—Capecitabine—colon cancer	0.000665	0.00257	CcSEcCtD
Iloperidone—Feeling abnormal—Irinotecan—colon cancer	0.000664	0.00256	CcSEcCtD
Iloperidone—Malnutrition—Capecitabine—colon cancer	0.00066	0.00255	CcSEcCtD
Iloperidone—Dysuria—Methotrexate—colon cancer	0.00066	0.00255	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000656	0.00253	CcSEcCtD
Iloperidone—Body temperature increased—Vincristine—colon cancer	0.000654	0.00252	CcSEcCtD
Iloperidone—Erectile dysfunction—Methotrexate—colon cancer	0.00065	0.00251	CcSEcCtD
Iloperidone—HTR2A—liver—colon cancer	0.000641	0.00508	CbGeAlD
Iloperidone—Body temperature increased—Irinotecan—colon cancer	0.000636	0.00246	CcSEcCtD
Iloperidone—Feeling abnormal—Fluorouracil—colon cancer	0.000635	0.00245	CcSEcCtD
Iloperidone—Muscle spasms—Capecitabine—colon cancer	0.000635	0.00245	CcSEcCtD
Iloperidone—Vision blurred—Capecitabine—colon cancer	0.000622	0.0024	CcSEcCtD
Iloperidone—Tremor—Capecitabine—colon cancer	0.000619	0.00239	CcSEcCtD
Iloperidone—Stomatitis—Methotrexate—colon cancer	0.000613	0.00237	CcSEcCtD
Iloperidone—Conjunctivitis—Methotrexate—colon cancer	0.000611	0.00236	CcSEcCtD
Iloperidone—Anaemia—Capecitabine—colon cancer	0.00061	0.00236	CcSEcCtD
Iloperidone—Body temperature increased—Fluorouracil—colon cancer	0.00061	0.00235	CcSEcCtD
Iloperidone—Hepatobiliary disease—Methotrexate—colon cancer	0.000595	0.0023	CcSEcCtD
Iloperidone—Epistaxis—Methotrexate—colon cancer	0.000593	0.00229	CcSEcCtD
Iloperidone—Vertigo—Capecitabine—colon cancer	0.000593	0.00229	CcSEcCtD
Iloperidone—Asthenia—Vincristine—colon cancer	0.000593	0.00229	CcSEcCtD
Iloperidone—CYP3A4—liver—colon cancer	0.000593	0.0047	CbGeAlD
Iloperidone—Leukopenia—Capecitabine—colon cancer	0.000591	0.00228	CcSEcCtD
Iloperidone—HRH1—lymph node—colon cancer	0.000588	0.00466	CbGeAlD
Iloperidone—CYP2D6—liver—colon cancer	0.000584	0.00463	CbGeAlD
Iloperidone—Palpitations—Capecitabine—colon cancer	0.000584	0.00225	CcSEcCtD
Iloperidone—Asthenia—Irinotecan—colon cancer	0.000578	0.00223	CcSEcCtD
Iloperidone—ADRA2A—lymph node—colon cancer	0.000578	0.00458	CbGeAlD
Iloperidone—Diarrhoea—Vincristine—colon cancer	0.000566	0.00218	CcSEcCtD
Iloperidone—Myalgia—Capecitabine—colon cancer	0.000562	0.00217	CcSEcCtD
Iloperidone—Arthralgia—Capecitabine—colon cancer	0.000562	0.00217	CcSEcCtD
Iloperidone—Urinary tract disorder—Methotrexate—colon cancer	0.000558	0.00215	CcSEcCtD
Iloperidone—Urethral disorder—Methotrexate—colon cancer	0.000554	0.00214	CcSEcCtD
Iloperidone—Diarrhoea—Irinotecan—colon cancer	0.000551	0.00213	CcSEcCtD
Iloperidone—Dry mouth—Capecitabine—colon cancer	0.00055	0.00212	CcSEcCtD
Iloperidone—Dizziness—Vincristine—colon cancer	0.000547	0.00211	CcSEcCtD
Iloperidone—Confusional state—Capecitabine—colon cancer	0.000543	0.0021	CcSEcCtD
Iloperidone—Oedema—Capecitabine—colon cancer	0.000539	0.00208	CcSEcCtD
Iloperidone—Infection—Capecitabine—colon cancer	0.000535	0.00207	CcSEcCtD
Iloperidone—Dizziness—Irinotecan—colon cancer	0.000532	0.00206	CcSEcCtD
Iloperidone—Nervous system disorder—Capecitabine—colon cancer	0.000528	0.00204	CcSEcCtD
Iloperidone—Eye disorder—Methotrexate—colon cancer	0.000528	0.00204	CcSEcCtD
Iloperidone—Diarrhoea—Fluorouracil—colon cancer	0.000528	0.00204	CcSEcCtD
Iloperidone—Tinnitus—Methotrexate—colon cancer	0.000526	0.00203	CcSEcCtD
Iloperidone—Tachycardia—Capecitabine—colon cancer	0.000526	0.00203	CcSEcCtD
Iloperidone—Cardiac disorder—Methotrexate—colon cancer	0.000524	0.00202	CcSEcCtD
Iloperidone—Rash—Vincristine—colon cancer	0.000521	0.00201	CcSEcCtD
Iloperidone—Dermatitis—Vincristine—colon cancer	0.000521	0.00201	CcSEcCtD
Iloperidone—Angiopathy—Methotrexate—colon cancer	0.000512	0.00198	CcSEcCtD
Iloperidone—Dizziness—Fluorouracil—colon cancer	0.00051	0.00197	CcSEcCtD
Iloperidone—Mediastinal disorder—Methotrexate—colon cancer	0.000509	0.00197	CcSEcCtD
Iloperidone—Rash—Irinotecan—colon cancer	0.000508	0.00196	CcSEcCtD
Iloperidone—Dermatitis—Irinotecan—colon cancer	0.000507	0.00196	CcSEcCtD
Iloperidone—Hypotension—Capecitabine—colon cancer	0.000504	0.00194	CcSEcCtD
Iloperidone—Mental disorder—Methotrexate—colon cancer	0.000495	0.00191	CcSEcCtD
Iloperidone—Malnutrition—Methotrexate—colon cancer	0.000492	0.0019	CcSEcCtD
Iloperidone—Nausea—Vincristine—colon cancer	0.000491	0.0019	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000491	0.0019	CcSEcCtD
Iloperidone—Rash—Fluorouracil—colon cancer	0.000486	0.00188	CcSEcCtD
Iloperidone—Dermatitis—Fluorouracil—colon cancer	0.000486	0.00188	CcSEcCtD
Iloperidone—Paraesthesia—Capecitabine—colon cancer	0.000484	0.00187	CcSEcCtD
Iloperidone—Dyspnoea—Capecitabine—colon cancer	0.00048	0.00186	CcSEcCtD
Iloperidone—Nausea—Irinotecan—colon cancer	0.000478	0.00185	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000465	0.0018	CcSEcCtD
Iloperidone—Fatigue—Capecitabine—colon cancer	0.000465	0.00179	CcSEcCtD
Iloperidone—Vision blurred—Methotrexate—colon cancer	0.000463	0.00179	CcSEcCtD
Iloperidone—Nausea—Fluorouracil—colon cancer	0.000458	0.00177	CcSEcCtD
Iloperidone—Anaemia—Methotrexate—colon cancer	0.000454	0.00175	CcSEcCtD
Iloperidone—Feeling abnormal—Capecitabine—colon cancer	0.000444	0.00172	CcSEcCtD
Iloperidone—Vertigo—Methotrexate—colon cancer	0.000442	0.00171	CcSEcCtD
Iloperidone—Leukopenia—Methotrexate—colon cancer	0.00044	0.0017	CcSEcCtD
Iloperidone—Body temperature increased—Capecitabine—colon cancer	0.000426	0.00165	CcSEcCtD
Iloperidone—Myalgia—Methotrexate—colon cancer	0.000418	0.00162	CcSEcCtD
Iloperidone—Arthralgia—Methotrexate—colon cancer	0.000418	0.00162	CcSEcCtD
Iloperidone—Confusional state—Methotrexate—colon cancer	0.000404	0.00156	CcSEcCtD
Iloperidone—Infection—Methotrexate—colon cancer	0.000399	0.00154	CcSEcCtD
Iloperidone—Nervous system disorder—Methotrexate—colon cancer	0.000393	0.00152	CcSEcCtD
Iloperidone—Asthenia—Capecitabine—colon cancer	0.000387	0.00149	CcSEcCtD
Iloperidone—Hypotension—Methotrexate—colon cancer	0.000375	0.00145	CcSEcCtD
Iloperidone—Diarrhoea—Capecitabine—colon cancer	0.000369	0.00142	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000365	0.00141	CcSEcCtD
Iloperidone—Paraesthesia—Methotrexate—colon cancer	0.00036	0.00139	CcSEcCtD
Iloperidone—Dyspnoea—Methotrexate—colon cancer	0.000358	0.00138	CcSEcCtD
Iloperidone—Somnolence—Methotrexate—colon cancer	0.000357	0.00138	CcSEcCtD
Iloperidone—Dizziness—Capecitabine—colon cancer	0.000356	0.00138	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000346	0.00134	CcSEcCtD
Iloperidone—Fatigue—Methotrexate—colon cancer	0.000346	0.00134	CcSEcCtD
Iloperidone—Rash—Capecitabine—colon cancer	0.00034	0.00131	CcSEcCtD
Iloperidone—Dermatitis—Capecitabine—colon cancer	0.000339	0.00131	CcSEcCtD
Iloperidone—Feeling abnormal—Methotrexate—colon cancer	0.000331	0.00128	CcSEcCtD
Iloperidone—Nausea—Capecitabine—colon cancer	0.00032	0.00124	CcSEcCtD
Iloperidone—Body temperature increased—Methotrexate—colon cancer	0.000317	0.00122	CcSEcCtD
Iloperidone—Asthenia—Methotrexate—colon cancer	0.000288	0.00111	CcSEcCtD
Iloperidone—Diarrhoea—Methotrexate—colon cancer	0.000274	0.00106	CcSEcCtD
Iloperidone—Dizziness—Methotrexate—colon cancer	0.000265	0.00102	CcSEcCtD
Iloperidone—Rash—Methotrexate—colon cancer	0.000253	0.000977	CcSEcCtD
Iloperidone—Dermatitis—Methotrexate—colon cancer	0.000253	0.000976	CcSEcCtD
Iloperidone—Nausea—Methotrexate—colon cancer	0.000238	0.00092	CcSEcCtD
